ClinicalTrials.Veeva

Menu

Genetic Developmental and Epileptic Encephalopathy Natural History Study for Clinical Trial Readiness

Weill Cornell Medicine (WCM) logo

Weill Cornell Medicine (WCM)

Status

Enrolling

Conditions

DEE
MEF2C

Treatments

Other: Observation

Study type

Observational

Funder types

Other

Identifiers

NCT07413211
24-10028107

Details and patient eligibility

About

Phase 0 non-interventional longitudinal study of children and adults with Developmental and Epileptic Encephalopathy (DEE) due to a genetic cause. There are six arms of the study. Arms 1, 2, and 3 are devoted to one example DEE, MEF2C Haploinsufficiency Syndrome (MCHS). Arms 4, 5, and 6 are open to all DEE. Arm 1 (in-person) will enroll children 0 to 15, who will make in-person visits to Weill Cornell Medicine four times over two years. Arm 2 (virtual) will enroll people of all ages and older who will make virtual visits over Weill Cornell Zoom to Weill Cornell Medicine over two years (2 if 16 and older; 4 if 0 to 15). Arm 3 (registry) will enroll people of all ages in an online-only survey. Arms 4 - 6 mirror this structure but they are open to all children with DEE. Arm 4 (in-person) will enroll children of any age, who will make in-person visits every 6 months for 10 years. Arm 5 (virtual) will enroll children of any age for virtual visits, twice a year of 0 to 15, once a year if 16 or older. Arm 6 (registry) will enroll people of all ages in an online only survey.

Enrollment

22,068 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria

  • Molecular diagnosis of a genetic disorder associated with DEE, as confirmed by the study investigators
  • A neurological phenotype such as epilepsy or developmental delay as confirmed by the study investigators.
  • English Speaking (Arms 1, 2, 4, 5). The registries may be completed by people who speak any language.

ARM 1 (In person cohort)

  • MEF2C
  • Age 0 to 15 at the time of study enrollment.
  • Willingness to travel to New York City four times over two years

ARM 2 (Virtual cohort)

  • MEF2C
  • Any age at the time of study enrollment
  • Sufficient internet connectivity to support video teleconferencing
  • Commitment to fill out all survey instruments

ARM 3 (Registry)

  • MEF2C
  • Any age at the time of study enrollment
  • Commitment to fill out one on-line instrument

ARM 4 (In person cohort)

  • Any DEE
  • Any age at the time of study enrollment
  • Willingness to travel to New York City four times over two years

ARM 5 (Virtual cohort)

  • Any DEE
  • Any age at the time of study enrollment
  • Sufficient internet connectivity to support video teleconferencing
  • Commitment to fill out all survey instruments

ARM 6 (Registry)

  • Any DEE
  • Any age at the time of study enrollment
  • Commitment to fill out one on-line instrument

Exclusion Criteria

  • Presence of a significant non-DEE-related central nervous impairment/behavioral disturbance that would confound the scientific rigor or interpretation of results of the study
  • History of prematurity (defined as gestational age <35 weeks), interventricular hemorrhage, structural brain deficit, or congenital heart disease
  • Presence of a clinical comorbidity deemed by the investigator to potentially confound the typical presentation of DEE

Trial design

22,068 participants in 6 patient groups

Onsite Cohort with MCHS
Description:
This is an in-person cohort of participants with MCHS under age 16 who will meet with investigators at the site location every 6 months for 2 years.
Treatment:
Other: Observation
Virtual Cohort with MCHS
Description:
* Has MCHS * Any age at the time of study enrollment * Sufficient internet connectivity to support video teleconferencing * Commitment to fill out all survey instruments
Treatment:
Other: Observation
MCHS Online Registry
Description:
* Has MCHS * Any age at the time of study enrollment * Commitment to fill out one on-line instrument
Onsite Cohort with any DEE
Description:
* Any DEE * Any age at the time of study enrollment * Willingness to travel to New York City four times over two years
Treatment:
Other: Observation
Virtual Cohort with Any DEE
Description:
Any DEE * Any age at the time of study enrollment * Sufficient internet connectivity to support video teleconferencing * Commitment to fill out all survey instruments
Treatment:
Other: Observation
DEE Online Registry
Description:
Any DEE * Any age at the time of study enrollment * Commitment to fill out one on-line instrument

Trial contacts and locations

1

Loading...

Central trial contact

Natalie Wayland, BS; Zachary Grinspan, MD MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems